Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MLYS | Common Stock | Options Exercise | $2.71K | +5.02K | +23.3% | $0.54* | 26.6K | Jan 11, 2024 | Direct | F1 |
transaction | MLYS | Common Stock | Options Exercise | $6.86K | +6.35K | +23.91% | $1.08* | 32.9K | Jan 12, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MLYS | Stock Option | Options Exercise | $0 | -5.02K | -7.69% | $0.00 | 60.2K | Jan 11, 2024 | Common Stock | 5.02K | $0.54 | Direct | F2, F3 |
transaction | MLYS | Stock Option | Options Exercise | $0 | -6.35K | -2.78% | $0.00 | 222K | Jan 12, 2024 | Common Stock | 6.35K | $1.08 | Direct | F4, F5 |
Id | Content |
---|---|
F1 | This balance includes 1,466 shares purchased under the Mineralys Therapeutics, Inc. 2023 Employee Stock Purchase Plan that were not previously reported. |
F2 | Due to a rounding error, the exercise price for this stock option was originally reported as $0.53 per share on the Reporting Person's Form 3 filed on February 9, 2023. |
F3 | The stock option vested with respect to 25% of the underlying shares on March 12, 2022, and vests with respect to the remaining shares in 36 substantially equal monthly installments thereafter. |
F4 | Due to a rounding error, the exercise price for this stock option was originally reported as $1.07 per share on the Reporting Person's Form 3 filed on February 9, 2023. |
F5 | The stock option vested with respect to 25% of the underlying shares on July 12, 2022, and vests with respect to the remaining shares in 36 substantially equal monthly installments thereafter. |